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INTRODUCTION 
It has been demonstrated repeatedly that heritable 
factors markedly Influence the response to disease. The 
operation of genetic factors obeying Mendelian principles 
has been shown to account for the natural resistance of a 
number of animal hosts to a variety of pathogenic and toxic 
agents. Reviews of the genetic aspects of natural re¬ 
sistance and of the host-pathogen relationship have been 
published by Crew (1), Kozelka (2), Lambert (3), Gowen 
(4, 5)» Parish (6), and Elberg (?)„ 
The studies on natural or inherent resistance deal 
with the reaction of the animal in Its initial contact with 
the pathogen. Under such circumstances, submission of the 
host to the pathogen or rejection of the disease occurs 
within a very short time and evidence is accumulating that 
this prompt response is not dependent upon antibody of either 
the induced or passively acquired varieties (8, 9)* but is 
rather due to non-humoral factors. These non-humoral, but 
genetically controlled factors which function in the response 
to disease remain at the present time largely unexplained. 
Although cellular factors, such as number of leukocytes (10, 
11), number and location of lymphocytes or macrophages (12, 
13i 1*0 and constitution of the liver and spleen (15); as 
well as n on-cel Tula r factors, such as increased body temper¬ 
ature (16, 17) and high blood pH (18) have been implicated as 

the source of natural resistance, all of these remain at the 
present time only associations and correlations. Genetic 
proof of their association with disease has not yet been 
supplied. Preliminary studies which have been done (19) 
indicate that inbreeding for increased number of leukocytes 
and high blood pH is accompanied by the loss of the correla¬ 
tion with resistance to disease. 
In contrast to the great number of studies on inherent- 
resistance upon first contact with disease, papers on the 
other factor of resistance, i.e., genetic control of antibody 
production, have been few in number. Some work has been done 
with regard to differences between inbred strains of animals 
in the ability to produce antibody. Lewis and Loomis (20) 
found that families of inbred guinea pigs differed in their 
capacity to produce hemolysins to bovine and sheep erythrocytes 
and agglutinins to typhosus and abortus. Prigge (21) 
demonstrated that different strains of guinea pigs had 
It 
varying responses to diphtheria toxoid. Schutze, Gorer and 
Finlayson (22) and Gorer and Schutze (23) found strain dif¬ 
ferences in the ability of mice to produce agglutinins to 
typhoid bacilli; they were unable to correlate the natural 
resistance of the strains upon first contact with typhoid and 
the capacity to produce antibody. In inbred rabbits Lurie (9) 
showed variation among rabbit strains in terras of antibody 
production to killed tubercule bacilli and found some cor¬ 
relation with innate resistance. Weiser, Golub and Harare (2b) 

found that strains of inbred mice differed in the ability to 
produce precipitins to egg white and that the strains with 
high precipitin titers were the most susceptible to anaphylaxis. 
Gowen (25) vaccinated six inbred strains of mice with in¬ 
activated typhimurium. The position of the strains 
relative to one another in terms of survival after challenge 
was the same in vaccinated and non-vaccinated animals although 
the vaccinated animals were more resistant to the challenge. 
He did not, however, measure antibody levels. Fink and 
Quinn (26) investigated the response of five strains of inbred 
mice to two different antigens 1 egg white and pneumococcus 
polysaccharide. Marked strain differences were found in the 
antibody titers to each antigen and the comparative ranking 
of the strains in terms of titer for the two antigens was 
entirely different. In Davidsohn and Stern’s work (27, 28) 
immune antibody to heterologous red cells was measured in 
eleven inbred mouse strains. There were definite statistical 
strain differences in the immune agglutinins and hemolysins to 
the sheep and chicken erythrocytes employed as antigens* 
the strain rankings for the production of sheep and chicken 
antibodies were different. Fink and Eothlauf (29) found dif¬ 
ferences in strains of mice in the capacity to produce antibody 
to egg albumin; the antibody level could not be correlated 
with the susceptibility to anaphylaxis. Ipsen (30, 31) 
tested iramuninability to tetanus toxoid indirectly by noting 
the survival time after a challenge of toxin. The mouse 
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straios differed in imraunizabillty, the degree of which bore 
no relationship to the natural resistance of the strains to 
tetanus toxin. Mueller, Wolfe, and McGibbon (32) immunized 
inbred chickens with bovine serum albumin and noted definite 
differences between the strains In terras of the total amount 
of circulating antibody nitrogen. 
In the works cited above the observed strain dif¬ 
ferences have been in general attributed to genetic control 
of antibody production. Although it is true on the basis of 
these studies to say that antibody production varies with 
the genetic constitution of the strain of animals employed, 
the source of these differences may not be attributed, per se, 
to genetic determinants. It is tempting in the presence of 
highly homozygous animals with intra-strain titers of small 
variance and very different Inter-strain titers to ascribe the 
observed differences between strains to the operation of 
genetic, chromosomal control. However, it is necessary to 
prove these presumed genetic determinants of antibody produc¬ 
tion through demonstration of heritability and characteriza¬ 
tion of the pattern of inheritance in order to rule out as¬ 
sociations of a non-chromosomal nature, either heritable, as 
in cytoplasmic inheritance, or non-Inherited such as en¬ 
vironmental factors. 
The first study attempting to define and characterize 
genetic control of the production of antibody was that of 
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Kleczkowski and Kleczkowska (33), who were able to divide 
rabbits into strong, medium and weak producers of antibody 
to human serum. The pattern of inheritance strongly suggested 
the segregation of a single gene, the homozygous gene giving- 
strong antibody production, its homozygous allele weak pro¬ 
duction and the heterozygous state intermediate production, 
Schiebel (3*0 inbred guinea pigs through six generations 
selecting for either good or absent production of antitoxin 
to diphtheria. The study showed that the capacity for anti¬ 
toxin production or non-production was hereditary and although 
it appeared to represent a simple, non-sex-linked, gene con¬ 
struction, the data were Insufficient to define more closely 
the Inheritance mechanism. Sang and Sobey (35) investigated 
the response of two strains of rabbits and their F* offspring 
to bovine plasma albumin and tobacco mosaic virus. Using 
the genetic technique of regression of offspring titers to 
those of the parents (the mean titers of the offspring and 
parents are plotted on a graph where the log of the parental 
mean titer is the abscissa and the log of the offspring mean 
titer Is the ordinate; the existence of a straight line joining- 
many such points Is taken as evidence of genetic inheritance), 
he estimated that antibody production to the tobacco mosaic 
virus was 90 per cent under genetic control. He was unable 
to demonstrate that genetic factors were important in 
determining the antibody response to bovine albumin. 
Common to these studies of antibody production in 
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inbred animals after Immunization is the determination of the 
presumably maximum serum titer attained or the mean survival 
time after challenge. The entire antibody response pattern, 
from appearance of antibody through its decline, has not been 
studied in inbred animals, and the probability of inter- 
strain differences and possible genetic control of the total 
response pattern also remain to be investigated. 
The present study was undertaken to investigate the 
extent and characteristics of the antibody response in strains 
of inbred mice, to obtain information about variation of the 
response pattern with different antigens and to determine the 
existence, extent and mode of inheritance of possible genetic 
control of the antibody response. The entire time-course of 
antibody production was studied, which Included: 1) the time 
of antibody appearance in the serum, 2) the rate of production, 
3) the time and amount of maximal antibody response, and 4) 
the rate of antibody decline. Information about the specificity 
of response was obtained through the use of two inactivated 
Type A influenza virus antigens and the measurement of two 
antibodies to each virus. Hie curves of antibody production 
of each antibody to each virus was plotted for each mouse 
strain and the resulting patterns compared. In addition, a 
third antigen, a single purified protein antigen was included 
originally to analyze further the specificity. Finally the 
inheritance of the observed patterns was studied in the first 
filial generation of reciprocal matings of the inbred strains. 
* 
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MATERIALS AND METHODS 
Experimental animals: Six strains of mice were employed. 
Three of the strainsj C57BR/c<3 Jax, AKR Jax and DBA/1 Jax 
were highly inbred strains obtained from the Jackson Memorial 
Laboratory, Bar Harbor, Maine; they have been inbred by 
sibling matings for over 4o generations and thus have reached 
the theoretical maximal attainable degree of homozygosity 
(22, 36). These three strains were derived originally from 
unrelated mice twenty to fifty years ago (37? 38). Two of the 
strains represented the first filial generation (F-j ) of the 
reciprocal mating of strains C57BR/cd and AKR; the strains 
were mated in this labor©.tory from parents supplied by the 
Jackson Laboratory. The sixth strain was an albino Swiss 
strain maintained in this laboratory for many years by In- 
breeding within the strain but without regard for sibling or 
other selective matings. This latter strain was presumed to 
consist of somewhat less homozygous animals. All of the mice 
were two to five months old at the beginning of the experi¬ 
ments; the average strain weights were? C57BR/cd, 23 grams; 
AKB, 29 grams; DBA/1, 20 grams; F-, of C5?BR/cd? x AKRcf, 25 
grams; of AKR? x C5?BR/cdd% 20 grams; and albino Swriss, 
30 grams. Mice were kept in plastic cages partially filled 
with sawdust and the cages were washed weekly. The cages. 
with five to 10 mice apiece, were stored in a constant 
■miMM 
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temperature (22°C), air-conditioned room and were given mouse 
food (Purina) and water ad libitum. 
era; Mice were lightly etherized and blood samples were 
obtained from the cavernous venous sinus through the infra¬ 
orbital route with the aid of a glass Pasteur pipette. With 
practice, 0,3 to 0,75 ml, of blood could be removed at weekly 
intervals from each mouse without significant morbidity or 
mortality. Mice were recaged after recovery from anesthesia. 
All mice were bled on each scheduled day. Mortality averaged 
under two per cent per bleeding. 
After clotting at room temperature, the blood samples 
were centrifuged twice at 2000 to 2500 RPM, The separated 
sera ’were inactivated at 56°C for 30 minutes and subsequently 
frozen at minus 28°C until the analyses. 
Antigens: Two strains of Type A influenza virus were employed 
as antigens, these were the PE-8 and A/Japan 305/5? strains. 
These viruses were maintained by serial allantoic egg passage, 
they were not mouse adapted. Nine to 10 day embryonated eggs 
were inoculated with 0,1 ml. of a 10~~ to !0"J dilution of 
the previous passage. After incubation at 3?'JC for 42 hours 
the eggs were refrigerated and the allantoic fluid harvested 
by syringe using a needle with multiple perforations. After 
every third egg passage each of the viruses was tested for 
contamination or gross change by cross hemagglutination- 
inhibition tests with standard antisera originally obtained 

from the Public Health Service Communicable Disease Center 
{Montgomery, Alabama), There was not evidence of contamina¬ 
tion or change during the seven to eight egg passages made 
for each virus during the one year course of these experiments. 
Bovine serum albumin (BSA) was used as the antigen 
in several of the experiments, BSA, Armour Fraction V, was 
dissolved in isotonic phosphate buffer and sterilized by 
filtration through sintered glass. It was diluted to the 
desired concentration with the same diluent. Alum precipitated 
BSA was prepared by the addition of seven per cent aluminum 
chloride slowly to a 10 mg. per ml, BSA preparation to the 
point of maximal turbidity. This preparation, which contained 
more than two-thirds of the total protein in the precipitate 
was then brought to pH 7 by the addition of N/10 NaOH. 
Purification of the Viruses: The virus-containing allantoic- 
fluids were first clarified by centrifugation for 10 minutes 
at 0°C at 10,000 RPM in a PR-2 centrifuge followed by ultra- 
centrifugation for 90 minutes at 0°C at 30,000 RPM. in a Spinco 
centrifuge. Four-fifths of the supernates containing insig¬ 
nificant hemagglutinin activity were discarded. The pellets 
were carefully resuspended in pH 7 phosphate buffer to ap¬ 
proximately the original volumes. The resulting suspensions 
were centrifuged once again for 90 minutes at 0°C at 30,000 
RPM and the pellets resuspended to about one-half the original 
volumes. Five hundred units of penicillin and 500 micrograms 
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of streptomycin were added per ml. and the preparations 
stored in aliquots at 0~4°C until use, 
/accines; The purified virus preparations were inactivated 
with betapropiolactone (BPL), a new non-toxic rapidly acting 
virucidal agent active In very low concentrations and said to 
inactivate viruses without loss of antigenicity (39? ^0, 4l). 
Equal volumes of purified virus and of 0.05$ BPL in distilled 
water were mixed at 0°C to give a concentration of 0.025$ BPL. 
The solutions were incubated at 3?°C for two hours to permit 
■ o 
hydrolysis of the BPL and immediately refrigerated, at 0-4 C 
until use. The vaccines were not toxic or infective for 
eggs in the undiluted state. 
Egg infectivity studies: The purified virus preparations 
before and after inactivation with BPL wrere tested for egg 
infectivity. Eggs were inoculated with 10-fold dilutions of 
the virus preparations, four to six eggs per dilution, as 
described under Antigens above. Allantoic fluid from in¬ 
dividual eggs was tested for hemagglutination of chicken 
erythrocytes and the 50 per cent infective doses (EIEq 5 
were computed according to the method of Eeed and Muench (42). 
Virus for hemagglutination-inhibition (HI) tests; HI test 
antigen was purified virus. Viral titrations of the prepara¬ 
tions were made by hemagglutination (HA) tests using viral 
dilutions (0.3 ml.) and a 0*5$ suspension of chicken eryth- 
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rocytes (0.3 ml.). The endpoint was 50 per cent or 2 (+) 
hemagglutination, A dilution of each preparation containing 
three HA doses was selected as the HI antigen, i.e., a dilu¬ 
tion which was three times as concentrated as that giving 
the HA endpoint. 
Virus for complement-fixation (CP) tests; CF test antigen 
was allantoic fluid clarified by low speed centrifugation. 
Optimal antigen concentrations for CF were determined by 
"checkerboard" titrations using allantoic fluid dilutions 
(0,5 ml.), mouse immune serum (0.2 ml.), five C’H^q units 
of guinea pig complement (0.5 ml.), and sensitized sheep 
erythrocytes (0.3 ml.). That dilution of each virus which 
gave maximum fixation of complement at the highest dilution 
of serum subsequently was used as the respective CF antigen. 
Chicken antisera: A chicken antiserum was prepared for each 
virus to be employed as a standard serum to be retitrated 
with each HI analysis as a check on reproducibility of the 
analyses. Chickens were given 10 ml. intravenously and 20 
ml. intraperitoneally of each purified virus preparation on 
the first day followed by 20 ml. by each route on the fourth 
day. One week following this second injection they were 
exsanguinated and the sera separated and frozen. The FR-8 
antiserum HI titer was 3000, it did not cross react with the 
Japan 305/5? virus. The titer of the Japan 305/57 antiserum 
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was 300j It cross reacted to less than a 1:10 dilution with 
the PR-8 virus. 
~omplement (C 1): Commercially prepared complement from Carworth 
Farms consisting of a fresh frozen pool of guinea pig serum 
was used. The C'* was titrated by the sheep cell hemolytic 
system and found to contain greater than 200 C®H^q units per 
ml. It was diluted for the analyses so that 0,5 ml. con¬ 
tained five C*H-_ units. 
50 
Chicken erythrocytes for the HI tests: A suspension of 
chicken red cells was prepared by washing the cells three 
times with NaCl followed by suspension in saline to yield an 
approximate 0.5 per* cent suspension. No red cells stored 
for more than four days post-bleeding were used. 
Sheep erythrocytes for the CF tests: One volume of sheep 
blood was collected into two volumes of Alsever®s solu¬ 
tion and stored in this form for no less than one day and 
no more than 30 days before use. Before being used, the 
cells were washed once with NaCl, thrice with Veronal 
buffer (VB) and suspended in VB. They were standardized 
on the Beckman spectrophotometer to an optical density of 
0.680, A complete description of the technique of sensitiza¬ 
tion may be found in Osier, Strauss and Mayer* (43). In 
brief, the standardized erythrocytes were sensitized with 
an equal volume of amboceptor (serum of rabbits immunized 
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with boiled sheep erythrocyte stromata) estimated to give 
about 1000 antibody molecules per red cell. The resulting 
suspension was Incubated at room temperature for 30 minutes 
and then refrigerated until use. 
Diluents t Isotonic sodium chloride (NaCl) was constituted 
as a 0.85 per cent solution. 
Phsophate buffer, pH 7 was made by the addition of 
seven parts of 0.10 M Na^HPO^ (1.42^) to two parts of 0.15 H 
KHoPOji^ {2.04/0. The pH was checked by meter. 
Alseve'r's anticoagulant solution consisted of 2.05 par 
cent glucose9 0.8 per cent trisodium citrate, and 0.42 per 
cent NaCl in distilled water. The pH was adjusted to 6.1 
with five per cent citric acid. 
Veronal buffer (VB) was made up as a five times 
isotonic stock solution which consisted of 4,19 per cent 
NaCl, 0,126 per cent NaHCG,,, 0.15 per cent sodium barbital 
and 0.23 per cent barbital in distilled water. Prior to use 
the stock was diluted to isotonicity with distilled water 
containing five ml. of 0.216 M MgCl^*6H20 and five ml. of 
0.03 M CaCl^'HgO per liter. 
Gelatin veronal buffer (Gel VB) was made as VB and 
contained in addition 50 ml. of one per cent gelatin per 
liter. 
The hemagglutination-inhibition (HI) testss Two-fold serial 
serum dilutions were made in VB from the heated mouse serum 
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beginning with a 1:10 to 1:30 dilution. The tests were run 
ft 
in Konte hemagglutination tubes. The reaction mixtures con¬ 
sisted of 0.3 ml. of mouse serum dilutions, 0.3 ml* of a 
dilution in VB of purified virus containing three HA doses, 
and 0.3 ml. of a 0,5/ suspension of chicken erythrocytes in 
NaCl. The tubes were allowed to stand for 20 minutes at room 
temperature before the erythrocytes were added. Virus and 
red cells were added with the aid of an automatic pipette. 
After 4o~60 minutes at room temperature the patterns of the 
settled erythrocytes were read visually taking 2 (+) 
hemagglutination as the endpoint. The reciprocal of the 
serum dilution producing this reactivity was recorded as the 
titer. Each analysis contained these controls: a tube with¬ 
out virus at the lowest serum dilution as a test for spontaneous 
hemagglutination; tubes without virus pr serum; a titration 
of the standard chicken antiserum to detect- variance between 
analyses; and, a hemagglutination titration of the virus in 
the absence of serum. With low-titered sera of certain strains 
(C5?BR/cd, DBA/1 and both F-^ strains) there were hemagglutinins 
for chicken erythrocytes in the sera. These sera were 
absorbed twice with chicken erythrocytes in packed form in 
a 1:10 serum dilution at 0°C, which was always sufficient 
to remove the agglutinins. In no case was a serum absorbed 
with chicken erythrocytes used in a CF analysis. 
The complement-fixation (CF) tests: Two-fold serial serum 
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dilutions were made from mouse serum in VB beginning with a 
1:10 to 1:30 dilution; the serial dilutions used in this test 
were in most cases the same ones as used in the HI tests. 
The tests were performed in 13 x 100 mm. tubes. After addi¬ 
tion of the serum dilution In 0.2 ml. volume, the tubes were 
cooled to 0°C and 0.5 ml. of C* (five C• ^ units) -was added 
to each tube. Then 0.5 ml. of the optimal dilution of allantoic 
fluid containing virus was added to each tube except the ap¬ 
propriate controls and all tubes were placed at 0°C overnight 
followed by a 20 minute incubation at 37°C. Subsequently 
0.3 ml, of sensitized sheep erythrocytes in Gel VB was added 
to each tube as the indicator for residual Cf and. the tubes 
were incubated further for 60 minutes at 37°C with inter¬ 
mittent shaking. Complement, virus and sensitized eryth¬ 
rocytes were added with an automatic pipette. The tubes 
were then centrifuged and the degree of lysis determined 
visually taking 2 ( + ) (50 per cent) lysis as the endpoint for 
expression of titer. The reciprocal of the serum dilution 
■producing this reactivity was recorded as the titer. Each 
analysis contained these controls: a tube without virus at 
the lowest serum dilution as a test for anti-complementary 
action of the serum; a control without serum as a test for 
anti-complementary action of the allantoic fluid virus 
preparation; a titration of a mouse serum repeated with each 
analysis to detect variance; and a complement titration 
containing only varying dilutions of complement plus diluent 
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and sensitized erythrocytes. Rarely the serum was anti¬ 
complementary at the 1:10 dilution, and in these cases this 
dilution was discarded. In no case was either a 1j2o serum 
dilution or the virus preparation anti-complementary. 
The CF test performed in the BSA experiments was 
identical in volumes and procedure with that just described 
except where otherwise indicated in the text. 
Capillary ring precipitin test: This test was used only in 
the BSA experiments. First antigen, then serum was drawn 
by capillary action Into Kimble melting-point tubes, the 
tubes being wiped before Insertion into the serum. They were 
placed vertically in plasticene and read at two and 24 hours. 




Part It The Immune response of four Inbred strains of mice 
Part I was a study of the immune response of four 
strains of mice to two related Type A influenza virus vac¬ 
cines, The strains of mice used and their ages at the 
beginning of the experiment werei 1) C5?BR/cd, three months* 
2) DBA/1, four months; 3) AKR, four months; and 4) albino 
Swiss,three months. Only females were employed. 
The PE-8 purified virus before inactivation had an 
EIDcq of 10'" per ml, and an HA titer of 400. Inactivation 
with BPL involved a 1:2 dilution of this preparation and made 
the virus non-infective for eggs. All mice received 0.5 ml, 
of this vaccine intraperitoneally on each of the scheduled 
days. There is no simple method of comparing doses of in¬ 
activated virus particles, therefore, in order to obtain a 
rough Idea of comparative dosage between the vaccines of 
Part I and Part II the vaccines were compared in terms of 
their EID^0, although in reality they were not infective for 
eggs. Thus, for PE-8, the dose of vaccine (0,5 ml,) was a 
1:2 dilution of the original purified preparation and thus 
contained one-fourth the original quantity of virus per 
ml. The Equivalent EID^q1* was therefore 0.5 x 10°, 
The Japan 305/5? virus preparation before inactivation 
had an EID,,^ of 10-’*' per ml, and an HA titer of 100, In¬ 
activation likewise involved a 1:2 dilution and the mice 
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similar ly received 0.5 ml. of the resulting vaccine. The 
"equivalent EID^q" was 1 x 10-^. 
Identical numbers of mice received each vaccine. 
Fifteen mice from each of the four strains received PE-8 
vaccine and 15 received Japan 305/5? vaccine. The 15 mice 
from each strain were in turn arbitrarily sub-divided into 
three groups of five mice apiece, and each of these three 
groups was treated as a unit, caged separately and their 
sera pooled. All 60 mice receiving each vaccine were treated 
identically as regards inoculation and bleeding. This 
protocol of division of the mice of each strain into sub¬ 
groups was followed in order to furnish sufficient serum for 
both serologic tests and to give also gross information about 
variance within each strain. All of the serum samples obtained 
were analyzed by both the HI and CF tests. 
The experiment extended over a period of six weeks. 
The times of injection and bleeding given below were Identical 
for mice receiving either vaccine and the volume of the 
vaccines was the same in each injection. The mice received a 
total of five intraperitoneal injections spaced over the 
first three weeks and were bled a total of eight times. 
Every mouse was inoculated and bled on the scheduled days. 
Day 0 mice bled 
1 mice injected 
4 mice bled 
5 mice injected 




Day 8 mice injected 
14 mice bled 
15 mice injected 
21 mice bled 
22 mice Injected 
28 mice bled 
35 mice bled 
42 mice bled 
The mice remained healthy and active throughout the 
experiment. Mortality, except for three mice which died 
Intercurrently, was confined to the time of bleeding and was 
probably due to anesthesia or exsanguination, The numbers 
given below represent the number of animals of the original 
15 in each strain remaining alive after 42 days. 
C5?BR/cd 11 Japan 305/5? C5?BR/cd 13 
DBA/1 8 DBA/1 10 
AKR 12 AKR 12 
Swiss 10 Swiss 11 
Cumulative mortality was thus 32 per cent for the PR-8 
experimental mice and. 24 per cent for the Japan 305/5? ex¬ 
perimental mice. 
Part II; The heritability of the Immune response 
Part II was a study of the characteristics of the 
immune response of two of the strains studied in Part I 
and of the first filial generation (F]_) of the reciprocal 
matings of these two strains. Unfortunately, due to limita¬ 
tions of time, the F? could not also be studied. The strains 
of mice used and their ages at the beginning of the experiment 
were: 1) C5?BR/cd, five months; 2) AKR, five months* 
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3) F- of C5?BR/cd$ x AKRcf , two to three months; and 4) 
F of AKB? x C5?BR/cdd,s two to three months. Only females 
of the first two strains listed were employed while mixed 
sexes of the progeny were used. The F^ strains were bred 
in this laboratory from parental strains obtained from the Jackson 
Laboratory. Part II took place one year after the study of 
Part I. 
The PR-8 and Japan 305/57 viruses represented, further 
egg passages of the viruses used in Fart I. They were purified 
and inactivated as described earlier. In an attempt to ob¬ 
tain the same dosage for each virus as used in Part I, the 
inactivated preparations were given to the animals in a dosage 
which was of roughly the same "equivalent SID' " as the 
j o 
respective viruses of Part I. It must be remembered however, 
that the vaccines were in reality not infective for eggs. 
For PR-8 the EID^q of the purified virus preparation was 
108*u per ml. and the HA titer was 480. Inactivation in¬ 
volved a 1:2 dilution. It was calculated that about 0.25 ml. 
of the newly prepared vaccine had an "equivalent EID^0M equal 
P 
to that of 0.5 ml. of the PR-8 vaccine of Fart I (0.5 x 10 ). 
Therefore 0.25 ml. was the dose of PR-8 vaccine given intra- 
peritoneally in each scheduled, inoculation. 
Similarly, the Japan 305/57 purified virus had an 
EIDrq before Inactivation of 10-7 and an HA titer of 600. 
Inactivation reduced the concentration by one-half and 
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calculations showed that I.25 ml. of this vaccine had the same 
"equivalent EID " as 0„5 ml. of the vaccine of Fart I, 
50 
namely 1 x 10J. Thus I.25 ml. was the dose of Japan 305/5? 
vaccine given intraperitoneally on each scheduled day. 
Due to improvements in technique and the desirability 
of being able to detect possible inheritance patterns, the 
serum of each mouse in Part II was analyzed individually. 
Organization of this part of the experiment with respect to 
caging, numbers of animals and general protocol was the same 
for mice receiving either PFi-8 virus vaccine or Japan 305/5? 
virus vaccine. Identical numbers of mice received each 
vaccine. Six mice from each of the four strains received 
each virus vaccine. The experiment extended over a period of 
28 days. The schedule was the same for the mice receiving 
either vaccine and the volume of each preparation given was 
the same in each injection. The mice received a total of four 
intraperitoneal Injections spaced over the first two weeks and 
they were bled a total of six times. All mice were injected 
and bled on the scheduled days, there was no serum pooling. 
Day 0 mice bled 
1 mice Injected 
4 mice bled 
5 mice injected 
? mice bled 
8 mice injected 
14 mice bled 
15 mice Injected 
21 mice bled 
28 mice bled 
_ 
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Data on mortality is given below. The mice remained 
healthy, deaths usually occurred on the day of bleeding during 
or immediately following the procedure. Three mice died 
intercurrently. The numbers of mice given below are the 
number of the original six per strain remaining alive after 
28 days. 
PR-8 C5?BR/cd 5 Japan 305/5? C5?BR/cd 5 
AKR 4 AKR 4 
Fxs C5?BR/cd+ x AKRcf 4 Fps C57ER/cd$.x AKRc? 
Fps AKR° x C57BR/cdo" 3 Fp: AKR$x C5?BR/cdo" 
Cumulative mortality was thus 33 per cent for the PR-8 ex¬ 
perimental mice and 2p per cent for the Japan 305/5? experi¬ 
mental mice. 
Part IIIi The response of Inbred mice to BSA 
Part III was intended as a study of the immune response 
of four strains of mice to a partially purified protein 
antigen. The antigen chosen was bovine serum albumin (BSA), 
The strains of mice employed and their ages were the same as 
those employed in Part I. Sera were analyzed by multiple 
serologic tests as described under Results. 
A pilot study using BSA as antigen was initiated in 10 
mice from each of the four strains. All mice were bled and 
injected on the scheduled days. The BSA, either soluble or 
alum-precipitated, was given intraperitoneally (ip) or sub¬ 
cutaneously (sc) in the listed dosages. The experiment ex¬ 







were bled a total of six times 
0 mice bled 
1 mice given 1 mg. soluble BSA ip 
4 mice given 1 mg. soluble BSA ip 
7 mice bled 
8 mice given 1.5 mg. alum-BSA ip 
14 mice bled 
15 mice given 1.5 mg. alum-BSA sc 
21 mice bled 
22 mice given 1.5 mg. a1urn-BSA ip 
33 mice bled 
48 mice bled 
The mice thus received a total of 6,5 nig, of BSA apiece. 
As the above immunization schedule failed to reveal 
antibody, a further study using protocols of intensive antigenic 
stimulation was initiated. Only Swiss mice were used in this 
portion of the experiment. Two separate immunization schedules 
involving heavy stimulation were devised, labelled as Groups I 
and II below, respectively. There were 10 mice involved in 
each of the groups; all mice were bled and injected on the 
respective scheduled days. This experiment extended over a 






















given 1.14 mg, soluble BSA iv and 2 mg, alum-BSA ip 
given 1,14 mg, soluble BSA iv and 2 mg. alum —BSA ip 
given 1,14 mg. soluble BSA iv and 2 mg, alum-BSA ip 
given 3 mg, soluble BSA iv and 3 mg® alum-BSA ip 
given 3 mg. soluble BSA iv and 3 mg. alum-BSA ip 
given 3.5 mg, soluble BSA iv and 4,5 nag. alum-BSA ip 
given 3,5 mg, soluble BSA iv and 4,5 mg. alum-BSA ip 
bled 
given 3,5 mg, soluble BSA iv and 4.5 mg. alum-BSA ip 
given 5 mg, soluble BSA iv and 6.45 mg. alum-BSA ip 
given 5 mg. soluble BSA iv and 6.45 mg. alum-BSA ip 
given 5 mg. soluble BSA iv and 9.7 mg. alum-BSA ip 
given 5 mg, soluble BSA iv and 12.9 mg. alum-BSA ip 
given 5 mg. soluble BSA iv and 12.9 mg. alum-BSA ip 
given 5 mg. soluble BSA iv and 12.9 ms. alum-BSA Ip 
bled 











mice given 3 rag. alum-BSA ip 
mice given 3 rag, alum-BSA ip 
mice given 3 mg. alum-BSA ip 
mice given 1.5 rag, soluble BSA Iv and 3 rag, alum-BSA ip 
dosage and schedule from day 5 through day 39 is 
identical with Group I. 
The total dose per mouse in Group I was 4o,64 mg, BSA 
intravenously and 80.15 mg. intraperitoneally for a total of 
18-9.79 mg. For Group II the intravenous dosage was 45 mg, and 





In the tables column "A" gives the titers obtained in 
the serological analyses and represents the titer of serum 
pools in Part I and the titer of individual mice in Part II. 
Column "B" gives the mean geometrical titer of the titers In 
column "A" and it is this figure, representative of the titer 
of each strain for each day of the study which was used in 
graphing the results. 
The "controls" in the tables and figures were sera which 
were retitrated with each analysis to determine reproducibility 
of the tests. In the HI tests this was a chicken antiserum 
to each virus while in the CF tests it was a mouse antiserum 
to each virus. 
Part I: The Immune Response of Four Inbred Strains of Mice 
General Results (Tables 1-4, Figures 1-4) It may be seen 
from the tables and graphs that the mouse strains demonstrated 
variation of strain titer with time which was of a greater- 
magnitude than could be accounted for by lack of reproducibility 
of the serological tests. It was unfortunately not possible 
to analyze the results of Part I statistically since the 
use of serum pooling precluded intra-strain variability in 
titer, and there is no statistical technique to compare 
series of identical numbers. 
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The pre-inoculation sera were in all cases negative 
for antibody by both the HI and CF tests. Neither PR-8 nor 
Japan 305/57 antisera cross-reacted with the heterologous 
virus in either serological test. 
Antibody was usually first demonstrable after two or 
three injections of antigen, on day seven or day 14, and from 
this point in each case the antibody response curve continued 
a steep rise to maximal titer. Cn day 14 or day 21 the slopes 
of the curves usually decreased and tended to flatten out to 
a more gradual increase in titer or to a plateau. Continued 
antigenic stimulation during this period of one to three weeks 
of approximately maximum response served, to maintain but not 
to increase markedly the titer. This gradual increase in 
titer or plateau persisted for one week or at most two weeks 
following the cessation of antigen inoculations and was im¬ 
mediately followed by a sharp fall in titer, generally in an 
exponential manner. In several instances it was possible to 
calculate the antibody half-life from this portion of the 
curve» 
This general pattern of response held true in general 
for both viruses and for both antibodies to each virus but 
there were, however, some differences between the viruses 
and their antibodies within this common framework. The 
PR-5 virus engendered higher titers in both the HI and CF 
tests than did the Japan 305/57 virus; the results of Part II 
indicated that this was not entirely due to the great dif¬ 
ferential in dosage of the two viruses received by the animals. 
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The PH-8 animals tended to show an earlier appearance of 
antibody with an earlier attainment of maximum titer as well 
as a longer persistence of antibody after the cessation of 
antigenic stimulation. The PR-8 curves therefore were generally 
higher and wider with an early rise to maximum titer and a 
long period at or near this level. The CF antibody appeared 
later than did the HI antibody and had lower titers, likewise, 
the CF antibody had a shorter half-life than the HI antibody, 
a confirmation of the well known characteristics of these two 
antibodies. 
The four mouse strains tended to group themselves into 
two differently reacting pairs: the two brown strains, 
C5?BE/cd and DBA/1 comprising one pair and the two albino 
strains, AKR and Swiss the other pair. This pattern usually 
was most marked during the early parts of the antibody response 
curves, that is, during the rise to the peak titer attained 
although it was sometimes true also for the plateau and 
exponential decline of the antibody level. The C5?BR/cd 
and. DBA/1 strains reached higher titers than the other* two 
strains in the HI test while this relationship was reversed 
in the results of the CF test. Similarly, the two brown 
strains had shorter antibody half-lives in the CF results 
than did the albino strains, half-life information from the 
HI results was incomplete. The Swiss strain, although Trained 
with the AKR strain during the first part of the curves there¬ 
after tended to react differently from the other strains in 
all but the Japan 305/57 CF analysis. 
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PH-8 Virus, HI response (Table 1, Figure 1) The results of 
this study demonstrated the grouping of the four strains 
Into two differently reacting pairs during the first half of 
the experiment followed by the loss of this pattern during 
the remainder of the study, the strains then varying in¬ 
dependently. The AKR and Swiss strains tended to react to 
lower titers than the DBA/I and C57BE/cd strain and their 
maximal titers were about two-thirds those of the latter 
strains. Throughout the experiment the albino animals 
reacted very similarly and their antibody response curves lay 
below those of the brown strains to the point of antibody 
decline although the difference was not striking after the 
twenty-first day. All strains had demonstrable antibody by 
the fourth day after only one injection of virus, this early 
appearance of antibody was evident elsewhere only in the PE-8 
HI study of Part II. The AKB and Swiss strains had an apparent 
drop in titer between the fourth and seventh days which was 
followed by a rise in titer. This drop in titer probably 
represented an anomaly of the experimental design due to the 
fact that the day four bleeding was followed on day five by 
an injection of vaccine. It is likely, therefore, that 
antigen was circulating in the serum on day seven, the time 
of the next serum sample, and was responsible for a falsely 
low level due to the neutralization of the antibody in the 
serum. The two brown strains reached their maximum titer on 
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day 14 after a total of three injections of antigen while the 
albino strains reached maximum titer on day 21, after four in¬ 
jections of antigen. This time difference may not have been 
that great due to the absence of intermediate serum samples. 
After reaching maximal titer on day 14 or 21 all four strains 
remained at about the same level of response through day 35 
and continued antigenic stimulation during this period, on 
days 15 and 22, did not serve to change the titers markedly. 
After day 35 all of the strains except the Swiss began to 
decline sharply to reach approximately one-half their 
respective maximum titers by day 42, 
Japan 305/57 Virus, HI response (Table 2, Figure 2) The 
results of this experiment illustrated also the pairing of 
the strains which was here, however, sharply limited to the 
first three weeks. During this part of the curves the AKB 
and Swiss again tended to react to lower titers. It will 
be noted here that the curves were still rising at the end of 
the antigen Inoculations and no true plateau was evident al¬ 
though there was a change in slope on day 14 for the brown 
strains and on day 21 for the albino strains. The maximal 
titer which was reached in this experiment was lower for 
the AKB and Swiss strains than it was for the C5?BB/cd and 
DBA/1 strains and in addition the albino strains demonstrated 
a later appearance of antibody. The dosage of antigen received 
by the Japan 305/57 animals in terms of either "equivalent EID^q** 
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or HA doses was much less than received by the PE-8 animals, 
and, if a similar reactivity of the mouse strains to the two 
viruses is assumed, the later appearance of antibody, the lack 
of a plateau and the fact that the curves did not reach peak 
production of antibody could be explained on the basis of the 
differential in dosage. Notable in this HI experiment also 
"was the pattern of the Swiss strain which promptly began to 
decline exponentially after day 21 despite continued injections 
of antigen. After day 28, one week following the last injec¬ 
tion of vaccine, the C5?BE/cd, DBA/1 and AKE strains began to 
decline sharply in titer. In the case of the C5?BE/cd and 
AKE strains where there were three weekly titer determina¬ 
tions in a straight exponential decline, the Japan 305/5? HI 
antibody half-life could be computed. For C5?BB/cd. this was 
A.A days and. for AKR it was 6.3 days. The half-life was not 
computed for the Swiss strain since its antibody decline 
began while antigen was still being given, 
PE-3 Virus, CF Response (Table 3» Figure 3) Some of the 
characteristics of the HI response were also present in this 
CF study however the patterns here were not very clear. Only 
the albino strains, AKR and Swiss were convincingly paired in 
their response and then only to the peak titer reached. This 
was achieved on day 28 after five injections of antigen. The 
C5?BE/cd and DBA/I strains were not paired. Strain DBA 
showed a definite plateau between days 14 and 28 despite 
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two further antigen inoculations during this periode The 
C57BE/cd strain dropped in titer between days 14 and 21 
only to rise to its original level of day 14 on day 28, this 
degree of variability might have been accounted for by varia¬ 
tions in the reproducibility of the test and C5?BR/cd there¬ 
fore may have had a plateau during this time period. It 
appears that the AKR and Swiss strains had not reached their 
maximum titer as the curves were still rising when antigenic- 
stimulation was stopped. Here also, it will be noted that 
the lag period was about one week following the last inocula¬ 
tion of antigen before the titers began to decline markedly. 
Since both the AKR and Swiss strains had three points on a 
straight decline their CF antibody half-lives could be 
determined. For AKR this was 4,9 days and for Swiss it was 
11*9 days. 
Japan 305/5? Virus, CF Response (Table 4, Figure 4) The 
results of this study demonstrated most conclusively the 
patterns observed in Part I, The pairing of the strains was 
here very evident and it extended beyond the period of rise 
to maximum titer and included likewise the decline of the 
antibody level. After an initial steep rise in titer of both 
pairs of animal strains the slope of the curves diminished on 
day 14 and continued to rise slightly. In this study, in 
contrast to the HI responses, the two albino strains had 
higher titers throughout the entire antibody response. It 

was notable that throughout their courses the two strains of 
each pair reacted to virtually identical titers* Maximum 
titer was attained for both pairs on day 28 and since all of 
the curves were still rising, it is probable that the strains 
had not reached their maximum response* Maximal titers of 
the two brown strains were about one-half those of the albino 
strains. One week after the last antigen injection all four- 
strains began an exponential decline in titer. Half-lives of 
the CF antibody could be computed for each strain and were; 
AKE, 4*4 days; Swiss, 4*5 days; C57BR/cd, 2.9 days; and 
DBA/1, 2,9 days, 
Part Hi The Herltabllity of the Immune Response 
General Results (Tables 5-8* Figures 5-8) The results of 
Part II were consistent and showed a similar type of re¬ 
activity which was independent of the virus or antibody test 
involved. Therefore it is possible to give the findings in 
general terms* 
Once again the graphs and tables demonstrated antigenic 
effect as seen by a comparison of the strain curves with 
the controls, l,e.s there was a rise in antibody production 
which could not be accounted for by lack of reproducibility of 
the tests or by a random distribution of reactivity. Statistical 
analysis was done on the results of Part II and is given at 
the end of this section. 
Pre-inoculation sera were always negative for antibody* 
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Neither PR-8 nor Japan 305/57 sera cross-reacted with the 
heterologous virus in either antibody test. Study of the 
individual mouse titers of the F strains given in the tables 
revealed intra-strain variation but no consistent subgroupings, 
rather the individual titers appeared to conform rather 
closely to the theoretical distribution of normal probability. 
The mean geometrical titer was therefore considered repre¬ 
sentative of individual titers for the purpose of graphing 
the results» 
The attempt to give the same dosage of each virus in 
Parts I and II was unsuccessful for the dosage of virus in 
Part II appears to have been greater than that of Part I, at 
least insofar as the dosage is reflected in the serological 
test results. There were several observations which pointed 
to a greater dosage in this part of the experiments 1) there 
was an earlier appearance of antibody (in all cases by day 
seven), 2) the early rise to maximum titer was very steep, 
3) maximum titer was achieved earlier in Part II and 4) 
all of the experiments demonstrated a "plateau effect" at 
maximum titer. The actual value of the maximum titer reached 
was not considered a function of dosage; this point is further 
considered in the Discussion. 
At day 14 In these experiments the slopes of the Curves 
of antibody production changed, a confirmation of the results 
of Part I, however in these experiments this was almost always 
a change to a plateau of titer with time. This plateau of 
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max imura titer extended from the fourteenth through the twenty- 
first day. A further dose of vaccine was given In all cases 
on day 15, however it is obvious that the resulting titer on 
day 21 was little changed from that present on day 14. This 
is a confirmation once again of the fact that each virus and 
each antibody has a maximal attainable titer which is in¬ 
dependent of the number of times a given dose was given and 
thereby, presumably, of the total dose of antigen. One week 
following tVie cessation of the antigenic stimulation the anti¬ 
body curves began to decline. Some of the strains appeared to 
have exponentially declining titers, but since the animals 
were not followed for longer than one week after the beginning 
of the loss of antibody titer, it was not possible to ascertain 
this probability. 
Within the general pattern of reactivity there was 
internal variation for both viruses and both antibodies 
studied. Animals which received PE-8 virus vaccine had higher 
titers in the HI test than those which received. Japan 305/57 
vaccine, while the CF titers were identical in the antisera 
to either virus. For each virus the respective CF titers 
were lower than the HI titers throughout the respective curves 
of antibody response. 
Once more, and here very dramatically, the four mouse 
strains of Part II tended to react according to two different 
patterns. The AKR and both F-, strains reacted very similarly 
if not identically up to the time of incipient antibody decline 
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while the C57BR/cd strain manifested a different pattern 
of reactivity during this period of time. It will be remembered 
that in Part I the AKR and C5?BR/cd strains were members of 
the two differently reacting mouse strain pairs respectively. 
This grouping of antibody response of the mouse strains was 
manifest in all of the antibody titrations of Part II, it was 
paralleled in extent only by the Japan 305/57 CP study of 
Part I. 
More specifically, it may be seen that the C5?BR/cd 
strain always reacted to lower titers in both serological 
tests than did the other three strains. In addition the curve 
of this strain had a distinctive shape in that on day It, 
when the slope of the curves of the other strains assumed a 
horizontal position, the C’5?BE/cd strain curve showed only a 
reduction in slope and continued to rise somewhat until one 
week following the last antigen inoculation. The response of 
the C5?BR/cd strain in the PR-8 HI study was somewhat anomalous 
during this first portion of the curve and its unusual pattern 
there cannot be explained. The maximum titer reached by 
the C5?BR/cd strain was always between one-third and one- 
half that of the remaining strains, this held true regardless 
of the virus or antibody test involved, it was likewise 
observed in the Japan 305/57 CP experiment of Part T. 
If actual titers are ignored, the similarity of all of 
the graphs of Part II is very striking. This observation 
has implications for a consideration of the antibody response 
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to two closely related antigens and to antigenic components 
of the complex, multiple-antigen-containing viral particle* 
Statistical analysis A rank sum test (44) was used to analyze 
the results. The individual titers of the animals in each 
strain were compared with those of every other strain for 
each day of the study. The results of the analyses for the 
antibodies studied is given below. 
PE-83 HI The C5?BE/cd strain was statistically different at 
at least P - 0,05 and usually at P < 0,01 from all other 
strains on days 7, 14, 21 and 28, There were no statistical 
differences between the AKR and F. strains on days 7» 14, 
21 or 28. 
PH-8, CF The C5?BH/cd strain was statistically different at 
at least P = 0,05 and usually at P< 0.01 from the AKR strain 
on days 1.4, 21 and. 28; from the F„ of C5?BR/cd 9 x AKR d* 
on days 7, 14, 21 and 28; and f rom the F-, of AKR ? x C5?BR/cd d* 
on days 7 and 28, There were no statistical differences be¬ 
tween the AKR and F1 strains on days 7, 14, 21, or 28, 
Japan 305/5?a HI The C57BR/cd strain was statistically dif¬ 
ferent at at least P = 0,05 and usually at P < 0,01 from the 
AKR strain on days 7? 14, and 28; from the F„ of AKR ? x 
C5?BR/cd p’and the of C5?BR/cd $ x AKE cP on days 7, 14, 21, 
and 28, On day 28 AKR and both strains were significantly 




Japan 305/57» CP The ■C5?BE/cd strain was statistically dif¬ 
ferent at at least P = 0.05 from AKB on days 14, 21 and 28; 
from the F, of AKE ? x C5?BR/cd cT on days 1^, 21 and 28; and 
from the of C57BS/cd ? x AKE (Ton days 14 and 28. On day 
7 F^ of AKR $ x C5?BR/cd cT were statistically different at 
? = 0,05 from all other strains; on day 28 AKE was different 
at P = 0.05 from F. of AKR + x C5?BR/cd cT, There were no 
other differences. 
"P11 roust be interpreted in the statistical sense 
and is defined as the probability of obtaining a difference 
as large or larger than that observed if in fact the strains 
did not differ at all. A value of 0,05 signifies a 
probability of 1 in 20, a "P4S of 0,01 a probability of 1 in 
100, In addition it must be mentioned that the strains were 
compared day by day and that the analysis does not take into 
account the difference of one entire curve from another. 
Interpretation of the results of the statistical analysis in 
this light further emphasizes the similarity of the AKE and F1 
strains to one another and their difference from the C57BR/cd 
strain. 
Part III; The Response of Inbred. Mice to BSA 
Mouse sera obtained from the six bleedings of the first 
immunization schedule for BSA described in Procedures were 
analyzed by OF using as antigen a BSA dilution which was 
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optimal in a "checkerboard" analysis with a BSA rabbit anti- 
BSA system. Five units of O’ were used, the volumes of serum, 
antigen, C* and sensitized sheep erythrocytes as well as the 
conditions of testing were exactly as used in analyzing the 
anti-viral sera. All of the serum samples proved to be negative 
for antibody. The sera were tested in the ring precipitin 
test in capillary tubes with a number of concentrations of 
BSA, there was no detectable precipitation. The possibility 
arose that perhaps the mouse BSA system had a markedly dif¬ 
ferent optimum combining ratio from the rabbit system from 
which the optimum antigen dilution was derived. If this situa¬ 
tion prevailed, it might have been possible that antibody was 
missed due to the presence of antigen or antibody excess. A 
"checkerboard" analysis using day 21 sera from the immunized 
mice was run with varying dilutions of the sera and of BSA 
by the CF technique. There was no detectable amount of C9 
fixed. Then, proceeding on the possibility that the mouse 
albumin system might be analogous to the horse anti- 
pneumococcal system which does not fix C9 in the usual CF 
protocol but does, in the presence of a large excess of C% 
fix some complement which may then be tested for by titration 
of the remaining C9. An assay of this tyioe employing 50 
units of guinea pig C5, several dilutions of the mouse day 33 
sera and two concentrations of BSA was performed. Titration 
for residual C* failed to show any fixation of Cf beyond that 
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amount remaining in the controls which contained neither 
antigen nor antibody. 
Since mice are less efficient than many other laboratory 
animals in producing antibody, more intensive schedules of 
immunization were devised on the chance that the mice had 
received insufficient antigen to stimulate the production of 
antibodies. Group I was a schedule of heavy stimulation 
with BSA given intravenously and intraperitoneally, Group II 
was a similar schedule which began with lighter stimulation to 
rule out the possibility of immune paralysis as described by 
Felton (45). In the schedules of Groups I and II there was 
an eight day rest period between days seven and 15 during 
which antigen was not given. Upon resumption of antigen 
inoculations on day 15 the mice in both groups developed 
anaphylactic shock and about J>0% died. This confirmed work 
which had shown that BSA could produce anaphylactic shock in 
mice (46, 47, 48) and incidentally demonstrated that the mice 
were not suffering from immune paralysis. It likewise estab¬ 
lished the existence of some antibody in the mice to account 
for the observed shock upon reinjection of BSA, 
In none of the sera from the three experimental bleedings 
of either the Group 1 or Group II mice was antibody demonstrable 
by the conventional CF test with either two or five units of 
complement. The capillary tube precipitin test gave similar 
results, "Checkerboard" analyses with varying dilutions of 
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antigen and serum In both the CF and ring precipitin tests 
likewise failed to demonstrate antibody. Analysis for pre¬ 
cipitating antibody using Ouchterlony*s technique of pre¬ 
cipitation in agar (49) was negative as were analyses em¬ 
ploying Freer’s reportedly more sensitive technique of pre¬ 
cipitation in semi-liquid agar in fine glass tubing (50). 
On the possibility that mouse C’ components attach in an un¬ 
usual manner, CF analysis was performed without the usual over¬ 
night period at 0°C, this was also unsuccessful. Immune 
adherence analyses (51) and hemagglutination with tannic 
acid treated erythrocytes (52, 53) were inconclusive, 
A test was then devised to detect any possible non¬ 
precipitating and non-complement-fixing antibody circulating 
in the mouse serum. This test was based on the assumption 
that were such an antibody present, it would combine with BSA 
thus decreasing the amount of uncombined BSA present. This 
reduction of the BSA concentration should then be detectable 
in the presence of an adequate indicator system. A standard¬ 
ized BSA rabbit anti-BSA system was selected as indicator. 
Accordingly a titration of a rabbit anti-BSA serum with an 
optimal dilution of BSA for the system was set up in capillary 
tubes. This same dilution of BSA was also incubated with 
varying dilutions of the day 33 mouse sera in test tubes. 
After incubation these BSA-mouse serum mixtures were used 
as the antigens in retitrations of the rabbit anti-BSA serum 
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in capillary tubes. After allowing for trie reduction in 
BSA concentration as a result of dilution with mouse serum the 
resulting titration of the rabbit serum was the same before 
and after incubation with the mouse serum. This indicated 
that the concentration of BSA had not changed. The test 
gave good evidence that the mice had no circulating antibody 
to BSA, 
The logical deduction was that the mice had antibody 
to BSA in their tissues and it was this antibody which 
explained the anaphylactic shock. This has been suggested by 
Malkiel (5*0 to explain the similar situation which pertains 
in mice immunized with egg albumin. The spleens, livers and 
samples of intestine were taken from the mice on day 39 at 
the conclusion of the experiment. The serosa was removed, 
the tissues minced and then homogenized in an omnimix. They 
were subsequently extracted with 0,25 M sucrose. The re¬ 
sulting suspensions were slow frozen and thawed three times 
to further lyse the cells. These preparations next were 
centrifuged in a PH-2 centrifuge at 0°C at 5000 BPM for 120 
minutes following which the supernatant fluids were removed 
and Inactivated at for 30 minutes. After a further 
centrifugation the preparations were stored 0 to 4°C until 
use; 500 units of penicillin and 500 raicrograms of strepto¬ 
mycin were added per ml, CP tests with the tissue extracts 
with two and five units of complement failed to reveal any 
fixation of the CJ„ Ring precipitin tests, Ouchterlony plate 

and Freer tube tests were all negative for antibody. The ex¬ 
tracts were then cross-tested in Ouchterlony plates with rabbit 
anti-BSA antiserum. There were strong lines of precipitation 
produced. This would be expected if the mouse tissue extracts 
contained residual BSA from the heavy Immunization schedule 
but also suggested the possibility that mouse albumin might 
be cross-reacting with the rabbit antiserum to BSA. To test 
this latter contingency spleen, liver, kidney, and intestine 
was taken from normal non-immunized Swiss mice and tissue 
extracts prepared as above described. These extracts were 
then tested in Ouchterlony plates with rabbit anti-BSA. There 
was strong cross-reactivity and the line of precipitation 
merged with that produced by the BSA rabbit anti-BSA control 
in the same plates. This represented good evidence that- 
mouse and bovine albumins are imraunologically related. All 
of the tissues examined gave this phenomenon. The significance 




The importance of genetic constitution as a determinant 
of antibody production is demonstrated by the results of this 
simultaneous study of the antibody response of two inbred 
strains of mice, and the F- strains of their reciprocal 
matings, to two Type A influenza viruses. The immune response 
as represented by the time curve of antibody production is 
heritable and its pattern of inheritance Indicates this 
heritability to be of chromosomal origin. It must be mentioned 
however that ultimate proof of genetic control of antibody 
production requires the F, generation and demonstration of 
segregation of the observed heritable genetic differences in 
antibody production. As the entire antibody response was 
studied, the extent and some of the characteristics of this 
presumptive genetic control of the immune response can be 
defined. 
It was evident from the results of Part II {Tables 5-3, 
Figs, 5-8) that the antibody response of the AKR and F-, 
strains was virtually identical in titer while the response 
of the C57BR/cd strain was distinctly different throughout 
the period of antibody production. This included the period 
from time of appearance of antibody to its incipient decline. 
Statistical analysis revealed the similarity of the AKR and 




bet ween those three strains and the C5?BR/cd animals. In 
view of this reproduction of the curve of the AKR parent strain 
by both of the F.. strains, the entire course of antibody 
production may be said to be heritable. As reciprocal matings 
of the parents were employed, it is possible, despite the 
absence of studies on the F;; and backcross generations, to 
rule out non-chroraosomal inheritance through the egg cytoplasm 
of the female parent and environmental influences of the 
female animal upon the developing embryo and fetus. The 
parental strains were of a highly homozygous nature, therefore 
it may be stated In view of this pattern of inheritance that 
the AKR strain is homozygous for the dominant gene or genes 
while the C5?BR/cd strain is homozygous for the recessive 
allele or alleles. Possession of the dominant gene or genes 
determined the maximal titer and also higher titers throughout 
the time of antibody production. It is also probable that 
these same genes were involved in the type of immune response 
engendered, for the AKR and both F strains had not only 
higher levels of antibody than the C57BR/cd, but their 
response curves were of a different form than that of the 
latter strain. The action of these genes Is apparently of a 
quantitative, not qualitative nature as all of the strains 
were capable of producing antibody of significant titer. 
This trait is not sex linked and there were no differences 
in reactivity between the male and female offspring. This 
latter point is shown by the lack of any subgroups among 

the individual titers of the F^ strains which were of mixed 
sexes, rather the F, titers for any one day appear evenly 
distributed about the mean for that day for each of the 
mouse strains. 
Thus the maximum antibody response was under probable 
genetic control, a confirmation of the results of Kleczkowski 
and Kleczkowska (33) and Sang and Sobey (35) • It is apparent 
that the entire spectrum of the production of antibody was 
heritable which Included the titers on each day, the response 
to repeated antigenic stimulation as well as distinctive 
aspects of the curves — the plateaus and the slopes of 
development of antibody. However, without the generation 
it cannot be determined whether the entire time-course of 
antibody production was a manifestation of the same gene or 
genes which determined the maximal response:. At the onset of 
antibody decline the curves separated and statistical sig¬ 
nificance was lost, presumptive evidence of the cessation 
of genetic control. The decline of the antibody level was a 
function of another type of control, as would be expected0 
There was insufficient data on this aspect of the antibody 
response in these studies to determine the nature of the 
antibody decay, it could be under direct genetic control or 
a manifestation of any number of constitutional factors. Un¬ 
fortunately there was not enough time available to examine 
for strain specificity with reference to "decay” of antibody. 
This could have been determined by measurements of half-life 
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of passively transferred antibody* 
The method of analysis was insufficiently sensitive 
to detect minor variations, however it is obvious that despite 
the difference in dosage of the two viruses the slopes, 
plateaus and general form of the curves for both viruses in 
each mouse strain were very similar provided actual titers 
achieved are ignored. Exactly the same observations apply 
to the CF and HI antibodies to each virus. With reference 
to this it will be noted that the C5?BR/cd strain titers were 
always one half those of the other strains regardless of 
the serological test or virus being considered. Thus, not 
only were the two antibodies to each virus very similar in 
reactivity if titer was excluded, but the two viruses seemed 
to generate very analogous responses and this response was 
true despite the different dosages of the antigens employed. 
It appears likely, although by no means proved that the same 
presumed genetic control of the response of the animals to 
these similar antigens also was in control of the response to 
antigenic components (the RA and CF antigens) of the complex 
viral antigen. 
This study has demonstrated the herltability of the 
antibody response, however it is necessary to discuss certain 
aspects of its possible mechanism. Since the average weight 
of inbred strains of mice is reproducible from generation to 
generation, their weight may be said to be a reflection of 
the genetic constitution of the strains. This being true, 

the possibility that the observed antibody response was a 
function of body weight arises? the smaller strains in 
receiving a proportionately greater dose of virus might 
thereby have produced more antibody. This could only have 
been true here if the weight of the F^ strains reflected 
the weight of the AKR strain, whose titers they mimicked. 
This was not the case. The average weights of the strains 
were: F-j of AKR ? x C5?BR/cd d*, 20 grams* C57BR/cd, 
23 grams; F-^ of C57BR/cd ? x AKR ef, 25 grams; and AKR, 29 
errs.ms . 
Similarly, differences in metabolic rates among the 
strains might have accounted for* the observed response, 
causing greater or lesser production and/or destruction of 
antibody. Wharton et al, (55) have suggested greater destruc¬ 
tion of antibody due to an increased metabolic rate to ac¬ 
count for low antibody levels in their tumor-bearing mice. 
Metabolic rate cannot be ruled out as an important factor 
in these mice because of the lack of data on this subject 
and the inability to determine its relative importance to 
antibody production and/or antibody destruction. Only 
inferences can be made insofar as the metablic rate was 
reflected, in gross differences in activity or excitability 
of the animals, as judged by casual observation during the 
12 months of this study. The AKR strain was the least active 
strain, while C'57BR/cd was significantly more active and the 
two strains showed greater and lesser titers of antibody 

respectively in Fart II. This would have been expected 
were increased metabolic rate accounting for increased 
destruction of antibody. Further evidence for this came from 
the half-life studies of Fart I where C5?BB/cd had an HI 
antibody half life of 4,4 days and AKB of 6.9 days while the 
CF half-lives were 2,2 and 4.4 days respectively to the 
Japan 305/57 virus. However, both F, strains were more active 
than either of the parental strains but produced antibody 
in an identical fashion to that of the inactive AKE strain. 
In addition, in Part I, DBA/1, which was the most excitable 
strain studied, had greater titers of antibody than the 
other strains to the PR-3 virus in both the HI and CF tests. 
Likewise, in Part I, the Swiss strain, much more active than 
AKB, was usually paired in terms of antibody production 
with that strain. Although metabolic rate cannot be ruled 
out it is probable that the inherited antibody patterns are 
a reflection of other aspects of genetic control. 
It is not possible to elucidate the origin of the 
observed genetic differences in the ability to produce anti¬ 
body. Probably the most obvious theory of these differences 
is to attribute them to differential rates of maturation of 
antibody producing stem cells, those strains with rapid 
maturation rates thereby producing antibody at a faster rate. 
Or, direct quantitative differences in the ability of mature 
lymphocytes, or the entire antibody producing tissue, to 

produce antibody of a certain level or type could be 
postulated. Other sites of action such as rates of clearing 
of antigen from the circulation or length of persistence of 
antigen in the tissues obviously influence antibody produc¬ 
tion and may be concerned. Similarly, produced antibody 
might be held in the tissues, the strains varying in the 
release of antibody to the circulation. However, the resolu¬ 
tion of this interesting and basic problem must await 
further work. 
Throughout this study individual animals and serum 
pools of a given strain had some variability of titer. Al¬ 
though inbred animals are of a high degree of homozygosity, 
there will continue to be phenotypic variation between animals 
(36, 56). This variation is usually less in degree than 
that of non-selected animals but need not be so (36, 57) • 
Its cause can only be given in generalities and represents 
the composite effect of many environmental factors, both 
internal and external acting upon or with the basic genetic 
predisposition for a certain response. These factors differ 
slightly between animals in their relative influence and 
nature. This diversity within strains has been shown in 
the case of antibody response to correspond to the curve of 
normal probability (35? 58). The presence of such phenotypic 
variation does not interfere with the demonstration of 
heritability of a particular characteristic although it is 
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present in the progeny as well as the parents of any mating, 
since, with the aid of statistical analysis one distribu¬ 
tion of figures may be compared with another. It might, also 
be said at this point that the rank sum test used in statistical 
analysis of the results of this experiment does not take 
into account the fact that the distributions of figures 
compared conformed to the curve of normal probability. Thus 
the statistical analysis tended to underestimate the 
similarities and differences between the strains of mice. 
The influenza virus is a highly complex antigenic- 
substance containing representatives of at least five groups 
of antigens: the neutralizing, flocculating, heraagglutinating, 
soluble (S) complement-fixing and viral (V) complement¬ 
fixing antigens. The Type of the virus is determined by 
its S antigen and its strain by its hemagglutinating antigen. 
This study measured the antibody response to the HA antigen 
and to the viral (V) complement-fixing antigen. Were anti-S 
rather than anti-V being measured, there would have been cross¬ 
reactivity of the C Fantisera which was not observed. In ad¬ 
dition, ultracentrifugation removed most of the soluble 3 
antigen and, most relevant, the S antigen usually does not 
stimulate good production of antibody in an Inactivated, 
virus preparation (59» 60). 
Although a spaced series of antigen Inoculations was 
given, the antibody response curve in these studies resembled 

the response to a single injection of antigen. No anamnestic 
response was evident. There was one aspect of the response 
curves which hears further comment. After an initial rise 
in antibody titer, there was a plateau with time of the maximal 
titer attained which was maintained until about one week fol¬ 
lowing the cessation of antigenic stimulation; during this 
period continued doses of antigen served to maintain but 
not to further increase the titer. This pattern was evident 
in all of the studies of Parts I and II where the maximum 
titer was reached prior to the last antigen injection. This 
type of maximal response to an antigen, an asymptotic type 
of curve, is a confirmation of a well known immunologic 
phenomenon (31, 61). 
In both Parts I and II the highest titer reached in 
the HI response to the PH-8 virus was about 1200. Likewise, 
in both Parts the CP response to either virus achieved a 
maximal titer of about 80 or 120. This suggests that 
there is a maximal attainable titer for both the HI and CP 
antibodies to each of these viruses which is independent 
of dosage as the viral dose in Part I and Part II was dif¬ 
ferent . 
It was not possible to account for the changed re¬ 
activity in the HI test of the C5?BR/cd and AKE strains of 
mice in Parts I and II. In Part I the C57BR/cd animals 
tended to have higher HI titers than the AKE strain during 

the first part of the antibody curves, while in Fart II 
this relationship was reversed. Age has been shown by Fink 
(26) and. Overman (62) to influence antibody response. The • 
age of the strains at the onset of the experiment in Part I 
were: C57BB/cd, three months and AKB, four months; and in 
Part II were: Cj??BR/cd five months and AKB, five months. 
It is difficult to see how such small age differences among 
adult mice should influence antibody production, however 
Fink (26) found very large differences in antibody production 
in mice of two and four months of age, both ages being 
presumably adult from the standpoint of immunological 
maturity. There was one year between Fart I and Part II 
however the caging and treatment of the mice was identical 
in both portions of the study. It Is very unlikely that a 
differentiation of one of the mouse strains to a subline 
occurred during this period of time. The virus antigens 
used in Part II were the direct descendents of those of Part 
I, but a slight change might have occurred with egg passage. 
The differences in reactivity were evident only in the HI 
test, which is less reproducible and more susceptible to 
non-specific influences than is the CF test. Although un¬ 
explained, this change in reactivity did. not obviate the 
results since within Parts I and II the findings were 
entirely consistent. 
The measure of dosage used In an attempt to equate the 
dose of virus in Parts I and II, the "equivalent was 
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evidently fallacious as the generated antibody response in 
the two halves of the experiment did not bear any relation¬ 
ship to this measure of dosage. Although the EID^r. does 
bear a relationship to the mouse infectivity dose in the case 
of live influenza viruses (63), this is not true with in¬ 
activated virus. This is a further confirmation of the fact 
that natural resistance and antibody production are based 
upon different factors. It likewise may be observed from 
study of the HA doses of Parts I and II for each virus that 
the antibody response is not in direct relationship with 
this measure of dosage either. 
The production of anaphylactic shock with B3A in this 
investigation is in agreement with the work of Solotorovsky 
(46), Cameron (47) and Terres (64) who likewise noted this 
phenomenon. The occurrence of anaphylactic shock represented 
evidence for the possession of anti-BSA by these mice. 
Solotorovsky (46) observed only small amounts of circulating 
antibody in his animals while Benedict (48) and Terres (64) 
found rather large amounts of circulating antibody in BSA 
immunized mice. In the present study no circulating antibody 
nor any tissue antibody was demonstrable by any of multiple 
serological procedures. Although it is unlikely that these 
mice possessed circulating antibody the inability to 
demonstrate tissue antibody does not mitigate against its 
presence. 
A very interesting result of this work was the observation 

that rabbit anti-BSA cross-reacted in Ouchterlony plates with 
normal, non-immunized mouse tissue extracts, and that the 
line of precipitation produced was continuous with that of 
the BSA rabbit anti-BSA control. As emphasized by Maurer 
(65) and Cohn (66), it is necessary to be extremely careful 
in interpreting the results of such cross-reactions; Wilson 
(67) has mentioned the hazards of studying such reactions 
in Ouchterlony plates. These cross-reactions, although not 
spurious, are influenced in degree by many factors, the most 
important of which is the length of immunization which is in 
direct proportion with the species cross-reactivity of the 
antibody produced (68, 69). Despite these cautions the 
demonstration of the observed mouse-bovine albumin im¬ 
munological relationship furnishes a convenient explanation 
of the lack of circulating antibody and the observed 
anaphylactic shock in the mice studied. One may postulate 
the theory that the injected BSA, being similar to the 
circulating and tissue mouse albumin, stimulated antibody 
production to only a portion of the protein, the dissimilar 
component. Hooker has also suggested multiple antibody pro¬ 
duction to a single homogenous antigen (70). The produced 
antibody would then have been adsorbed onto the albumin of 
the serum and of the mouse tissues being rendered thereby 
non-detectable. After assimilation during the rest period, 
reinjected BSA then combined with this anti-albumin in the 
tissues and it was this reaction which was responsible for 
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the anaphylactic shock. 
This cross-reacting system may be added to several 
other known inter-species irnrnunologically related albumins. 
Mouse and human albumins have been shown by Clausen (71) 
to cross-react irnrnunologically as have human and bovine 
albumins by Melcher (72), Maurer (65) and Naylor (73). 
Human and horse albumin have also been shown to cross- 




The entire time-course of antibody production was 
studied in four inbred strains of mice and the Fn progeny 
of reciprocal matings of two of the strains. Two inactivated 
Type A influenza viruses were given as antigens in a series 
of multiple inoculations and the antibody response was 
analyzed by both the hemagglutination-inhibition and com¬ 
plement-fixation techniques. The time of antibody appearance, 
its slope of production, the time and amount of maximum 
response, the slope of decline and general characteristics 
of the antibody curves were studied and the pattern of in¬ 
heritance of these elements of the immune response in the F-, 
-L 
strains was delineated. 
The results of this study demonstrated genetic 
heritability of the immune response and represented pre¬ 
sumptive evidence for genetic control of antibody produc¬ 
tion although the absolute demonstration of control lies 
in the study of the segregation of the observed heritable 
patterns in the F,; generation. The entire curve of produc¬ 
tion of antibody to the time of incipient decline of the 
antibody level was found to be chrornosocially inherited. One 
strain of mice, AKR, was homozygous for the dominant gene 
or genes while another strain, G5?BR/cd carried the homozygous 
recessive allele. Dominance was manifest in higher titers 
and a distinctive curve of antibody response. The genes 
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controlling the maximum response and the total immune 
response appeared as well to function in the determination 
of the hemagglutination-inhibition and complement-fixation 
response to both of the closely related viruses. The 
implications of these findings are discussed. 
In addition, the response of the mice to bovine serum 
albumin (BSA) was investigated. Although originally Intended 
as a third antigen for characterization of the immune response, 
several protocols of intensive antigenic stimulation failed 
to elicit antibody detectable either in the serum or tissues 
by multiple serological techniques. However, following a 
lapse of injections of antigen, reinoculation of BSA resulted 
in anaphylactic shock in the mice. Investigations into the 
cause of the shock and of the absence of antibody ultimately 
revealed the presence of an immunological cross-reacting system 
in bovine and mouse albumins, It is presumed that the mice 
produced antibody to only a portion of the injected, antigenlcally 
similar albumin, that this antibody was quickly adsorbed 
onto mouse albumin in the tissues and that the reinjection 
of BSA- resulted In antigen-antibody reactions in the tissues 
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Part I: Hemagglutination-inhibition antibody response 
curve to PR-8 virus. The control represents a series 
of repeated, titrations of the same serum, It is not a 




Part I: Remagglutionation-inhibition antibody response 
curve to japan 305/57 virus. The control represents a 
series of repeated titrations of the same serum, it is 
not a curve of antibody production. For convenience9 




Part I i Complement-fixation antibody response curve to 
PR-3 virus. The control represents a series of repeated 
titrations of the same serum, it is not a curve of anti¬ 
body production. For convenience, the control is plotted 
one log above actual titer. 

FIGURE 4 
Part Is Complement-fixation antibody response curve to 
Japan 305/5? virus. The control represents a series of 
repeated titrations of the same serum, it is not a curve 
of^antibody production. The control is plotted one log 
below actual titer. 

FIGURE 5 
Part II: Keraagglutination-inhibition antibody response 
curve to PE-8 virus. The control represents a series of 
repeated titrations of the same serum. It is not a curve 
of antibody production. For convenience, the control is 




Part II: Hemagglutination-.inhibit.! on antibody response 
curve to Japan 305/57 virus. The control represents a 
series of repeated titrations of the same serum, it is 
not a curve of antibody production. For convenience, 
the control is plotted one log below actual titer. 

FIGURE 7 
Part II: Complement-fixation antibody response curve 
to FE-8 virus. The control represents a series of 
repeated titrations of the same serum, it is not a 
curve of antibody production. For convenience, the 




Part II: Complement-fixation antibody response curve to 
Japan 305/57 virus. The control represents a series of 
repeated titrations of the same serum, it is not a curve 
of antibody production. For convenience, the control is 
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